- Home
- Actualités & évènements
- Conférences & évènements
- Hemostasis Science Weeks 2021

Hemostasis Science Weeks 2021
Connecting experts around the world and across healthcare specialties
Watch on-demand webinars
Hemostasis Science Weeks is a free, online scientific series that helps connect lab and clinical experts around the world. In this forum, leading independent hemostasis experts share scientific insights into current clinical practice, what’s new, and what’s coming in hemostasis testing.
Join PEPconnect to:
- Watch scientific sessions with renowned experts.
- Attend sessions that are relevant for your practice.
- Create a personalized agenda according to your interests and schedule.
Choose your sessions!
If hemostasis plays a role in your healthcare specialty, these webinars will deliver valuable information and insights for your daily practice. Anyone may watch any session. If you are in doubt about which session may be right for you, please click through the interactive recommendation below.
Lab professionalsHemostaseologistsAnesthesiologistsCardiologistsGynecologistsPhysiciansAgenda
Join renowned speakers in five sessions to gain insights into the latest developments in hemostasis testing and the management of coagulation disorders.
Chairman: Prof. Dr. Ulrich Sachs

Session 1:
COVID-19–associated Coagulopathy
COVID-19–associated Coagulopathy
Join this session to learn about the impact of COVID-19 on hemostasis and the pathophysiology of associated coagulopathy. Learn more about recommended laboratory testing and patient management of coagulation in COVID-19.
View full session details.
Title
Speaker
Speaker Bios
Introduction
Prof. Dr. Ulrich Sachs
Giessen, GermanyStrong Impact on Hemostasis
in COVID-19 PatientsProf. Dr. Sophie Susen
Lille, FranceLaboratory Testing in COVID-19
–associated CoagulopathyDr. Jecko Thachil
Manchester, United KingdomImmunothrombosis in COVID-19–
associated CoagulopathyDr. Leo Johannes Nicolai
Munich, GermanyManaging COVID-19–associated
CoagulopathyProf. Dr. Alex Spyropoulos
New York, USA

Session 2:
Managing the Bleeding Patient
Managing the Bleeding Patient
In this session, experts discuss improvements in hemophilia patient management in recent years. Join this session to learn how they not only affect treatment but also the laboratory.
View full session details.
Title
Speaker
Speaker Bios
Introduction
Prof. Dr. Ulrich Sachs
Giessen, GermanyExtended Half-life Coagulation
Factors for Hemophilia Therapy:
Clinically Advantageous, Challenging
for the LaboratoryDr. Stefan Tiefenbacher
Englewood, USAEmicizumab for Routine Prophylaxis
in Hemophilia A: Clinical and
Laboratory ExperiencePD Dr. Jens Müller
Bonn, GermanyHemostasis Derangement during
Mechanical Circulatory SupportPD Dr. Dr. Ingvild Birschmann
Bad Oeynhausen, GermanyBiology Network Modeling:
New Targets in Hemophilia TherapyProf. Dr. Víctor Jiménez-Yuste
Madrid, Spain

Session 3:
Hemostasis Testing in Cardiac and Vascular Disease
Hemostasis Testing in Cardiac and Vascular Disease
Prevention of acute thrombosis using anticoagulants is the primary strategy in patients suffering from cardiovascular disease. This session gives insights on laboratory parameters that are key in patient and therapy management.
View full session details.
Title
Speaker
Speaker Bios
Introduction
Prof. Dr. Ulrich Sachs
Giessen, GermanyTesting for Direct Oral Anticoagulants
(DOACs): When and HowProf. Dr. Hugo ten Cate
Maastricht, the NetherlandsDrug Levels, Bleeding, and Thrombotic
Outcomes in Patients under Direct
Oral AnticoagulantsDr. Sophie Testa
Cremona, ItalyThe Utility of D-dimer and F1+2
in Cardiovascular Disease and
Anticoagulation ManagementAssoc. Prof. Dr. Christina Christersson
Uppsala, SwedenReal-time Monitoring of von Willebrand
Factor in the Catheterization Laboratory:
The Seatbelt of Mini-invasive Transcatheter
Aortic Valve ReplacementDr. Flavien Vincent
Lille, France

Session 4:
Hemostasis Management in Pregnancy and Obstetrics
Hemostasis Management in Pregnancy and Obstetrics
This session focuses on thrombotic events occurring in pregnancy. Hear more about recommendations for managing women at risk of thrombosis or DIC in clinical practice.
View full session details.
Title
Speaker
Speaker Bios
Introduction
Prof. Dr. Ulrich Sachs
Giessen, GermanyThrombophilia and VTE
in PregnancyProf. Dr. Birgit Linnemann
Regensburg, GermanyHemostatics Aspects of Peripartum
Hemorrhage and Impact of Factor XIIIProf. Dr. Wolfgang Korte
St. Gallen, SwitzerlandDisseminated Intravascular Coagulation
in Pregnancy: Insights in Pathophysiology,
Diagnosis, and ManagementDr. Jecko Thachil
Manchester, United Kingdom

Session 5:
New Insights in Mechanisms and Management of the Hemostatic Balance
New Insights in Mechanisms and Management of the Hemostatic Balance
In this session, experts discuss new insights into the coagulation process. Learn more about novel factors and mechanisms that can affect thrombosis and bleeding and how they can be managed.
View full session details.
Title
Speaker
Speaker Bios
Introduction
Prof. Dr. Ulrich Sachs
Giessen, GermanyTime to Change the Classical Vision
of Coagulation in Liver Disease: From
Balance Disequilibrium to SystemsDr. Joan C. Reverter
Barcelona, SpainCoagulation Factor XII in
Thrombosis and InflammationProf. Dr. Dr. Thomas Renné
Hamburg, GermanyRole of Complement Factor H
in HemostasisDr. Meike Heurich-Sevcenco
Cardiff, United Kingdom
Powered by hemostasis experts, presented by Siemens Healthineers
During this time of uncertainty, safety must be our top priority. But we also believe that, especially during the pandemic, staying informed about trends and developments in hemostasis testing is essential. To provide scientific insights flexibly and safely, we will bring this event to you virtually.
As a leader in hemostasis testing, Siemens Healthineers passionately supports hemostasis research and sharing of scientific insights to make them accessible to experts around the world.
#HSW21